Bacterial infections Trials in Louisville, United States
Conditions / Bacterial infections / Louisville, United States
Bacterial infections has been the subject of sustained clinical investigation across multiple research sites.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00488345 | Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age | COMPLETED | PHASE2 |
| NCT05614895 | A Study to Investigate the Pharmacokinetics of RO7223280 in Critically Ill Participants With Bacterial Infections | COMPLETED | PHASE1 |
| NCT01744730 | Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile | COMPLETED | PHASE1 |
| NCT03617042 | Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection | RECRUITING | PHASE1 |
| NCT02688790 | Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection | TERMINATED | PHASE1 |
| NCT02527681 | Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics | TERMINATED | PHASE1 |
| NCT01966055 | Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents | COMPLETED | PHASE1 |
| NCT00575380 | Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery | COMPLETED | PHASE4 |
| NCT00035854 | New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus) | COMPLETED | PHASE3 |
| NCT01946568 | A Single Dose Study To Investigate The Pharmacokinetics and Safety Of Dalbavancin In Hospitalized Children Aged 3 Months to 11 Years. | COMPLETED | PHASE1 |